Please complete the CAPTCHA to continue
@ricerca.com
✓
6 phones found area 210, 484, 440, and 610
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Michael Placke is listed as Senior Leader and Expert in Nonclinical Development at Drug Development Insights, LLC, based in Greater Boston, United States. AeroLeads shows a work email signal at ricerca.com, phone signal with area code 210, 484, 440, 610, and a matched LinkedIn profile for Michael Placke.
Michael Placke previously worked as President at Drug Development Insights, Llc and Head, Global Nonclinical Development and US Drug Discovery at Shire Pharmaceuticals. Michael Placke holds Ph.D., Pathobiology & Toxicology from The University Of Connecticut.
This section adds company-level context without repeating Michael Placke's masked contact details.
AeroLeads found 1 current-domain work email signal for Michael Placke. Compare company email patterns before reaching out.
Dr. Placke is a highly experienced pharmaceutical drug development executive with over 35 years of pharmaceutical industry experience, including scientific and operational responsibilities for multi-disciplinary pharmaceutical development operations, including Drug Safety and Metabolism (DSM), Discovery Research, and Chemical Product Development (CPD) Divisions in large pharmaceutical and biopharmaceutical companies. Most recently, Head, Global Nonclinical Development & US Drug Discovery at Shire Pharmaceuticals. Prior to this was Senior Vice President of Drug Safety and Metabolism at Alnylam Pharmaceuticals, and prior to Alnylam was President & CEO of Ricerca Biosciences. Previously was VP, Drug Safety at Wyeth Pharmaceuticals (and Pfizer post acquisition), and before joining Wyeth he was VP, R&D of a private equity/venture-funded start-up firm developing novel respiratory drug therapies. He has experience in developing a wide array of drug product modalities including small molecules, biologics, siRNA therapies, vaccines, and specialty drug products. He has led multiple organizations with operating budgets of $40 - 50M and over 300 staff. Dr. Placke has a record of accomplishments in research and development of advancing drugs from late discovery through market registration, with advanced leadership skills and expertise in assessment of new pharmaceutical therapies and technologies. He is formally trained in experimental pathology and toxicology, earning BS and MS degrees from The Ohio State University and his PhD from the University of Connecticut. He is board certified in general toxicology, and was a director and officer of the American Board of Toxicology.
Listed skills include Drug Development, Pharmaceutical Industry, Biotechnology, Cro, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Provide executive and scientific leadership to biopharmaceutical companies in early Research and non-clinical development strategies for both regulatory development and scientific investigations. Will lead R&D functions or serve as entrepreneur in residence for early biotechnology companies.
Cambridge, Ma
Lead and managed an R&D function combining Global Nonclinical Development and US Research. The nonclinical functions included toxicology, pathology, DMPK, bio-analytical and biomarkers, nonclinical regulatory submissions, in vitro diagnostics and operations. The Research function included discovery biology, pharmacology and Discovery Therapeutics and Modality development (core capabilities in monoclonal antibodies, proteins, peptides, gene therapy, oligonucleotides, gene editing technologies and small molecules), all focused on rare diseases. A member of the Shire Research and Development Leadership Team (RDLT) and Pipeline Committee, which are governance committees guiding product development, and overall R&D strategy for Shire, with responsibility for developing Shire as a world leader in specialty pharmaceuticals and rare diseases.
Cambridge, Ma
Responsible for leading all nonclinical development operations and activities at Alnylam, a biopharmaceutical company focused on the discovery, development and commercialization of siRNA therapies. This includes both the Drug Metabolism, Pharmacokinetic and Drug Safety efforts supporting research and early discovery, platform technologies, and a rapidly expanding portfolio of clinical-development stage therapeutics. Alnylam’s focus is leading the translation of RNAi, as a new class of innovative medicines, with a portfolio of RNAi therapeutics developed toward genetically defined targets for the treatment of serious, life-threatening diseases with limited treatment options for patients. The majority of these therapeutics are coupled with novel targeted delivery systems concentrating their effect at the disease target, while minimizing adverse side effects. The nonclinical team provides innovative scientific approaches to understanding this unique class of complex therapies and their biologic effects and outcomes, in addition to required regulatory assessment of the metabolism, fate and safety of clinical candidates.
Concord, Ohio
Dr. Placke was President & CEO of Ricerca Biosciences, LLC, a privately held contract research company, located on a single 43 acre campus in Concord, Ohio, offering integrated non-clinical drug development services to the biopharmaceutical and pharmaceutical industries, in addition to an independent Agrochemical Product Development Division supporting the registration and re-registration of agrochemicals and fine chemical products. Upon first joining the firm in 2010 was responsible for all Ricerca Concord, Ohio site technical and operational functions for the 3 major research divisions; Drug Safety and Metabolism (DSM) Division and Chemical Development Division, & Agrochemical product development division. After becoming President and CEO, Dr. Placke lead a major restructuring effort to improve corporate financial performance, shareholder value and made multiple operation changes to enhance technical and scientific capabilities and position Ricerca as a leading provider of core pharmaceutical and ag/chem product development services.
Chazy, New York
Responsible for managing the non-clinical safety evaluation of pre development and development candidate compounds for Wyeth Research. Line management responsibility for drug development operations dedicated to Regulatory Toxicology, Reproductive Toxicology, Safety Pharmacology, Formulations & Analytical Chemistry, Pathology, Clinical Pathology, Veterinary Services, Bioresources and Pre-development/Discovery Support, and for all senior scientific Drug Safety and Metabolism representation on Project Teams. Site head for Chazy Drug Safety Site, which was Wyeth’s global center for drug safety operations. Operational responsibilities include over 300 staff and project resource allocation across 3 global sites and managing annual Toxicology Contract Budget and CRO support to Development Portfolio. Following Pfizer acquisition, retained all legacy Wyeth R&D responsibilities, along with integration of legacy Wyeth assets into Pfizer R&D portfolio.
Quick answers generated from the profile data available on this page.
Michael Placke works for Drug Development Insights, LLC.
Michael Placke is listed as Senior Leader and Expert in Nonclinical Development at Drug Development Insights, LLC.
AeroLeads has found 1 work email signal at @ricerca.com for Michael Placke at Drug Development Insights, LLC.
AeroLeads has found 6 phone signal(s) with area code 210, 484, 440, 610 for Michael Placke at Drug Development Insights, LLC.
Michael Placke is based in Greater Boston, United States while working with Drug Development Insights, LLC.
Michael Placke has worked for Drug Development Insights, Llc, Shire Pharmaceuticals, Alnylam Pharmaceuticals, Ricerca Biosciences, and Pfizer (Formerly Wyeth).
You can use AeroLeads to view verified contact signals for Michael Placke at Drug Development Insights, LLC, including work email, phone, and LinkedIn data when available.
Michael Placke holds Ph.D., Pathobiology & Toxicology from The University Of Connecticut.
Michael Placke is listed with skills including Drug Development, Pharmaceutical Industry, Biotechnology, Cro, Glp, Toxicology, Drug Discovery, and Biopharmaceuticals.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Michael Placke you were looking for.
View similar profiles
